NCT00269997View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1990

Conditions
AnemiaNeoplasms
Interventions
DRUG

epoetin alfa

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00269997 - A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug | Biotech Hunter | Biotech Hunter